Oscar Health Inc
(MEX:OSCR)
MXN
536
+18 (+3.47%)
Market Cap: 161.61 Bil
Enterprise Value: 85.46 Bil
PE Ratio: 0
PB Ratio: 5.53
GF Score: 53/100 Q1 2024 Oscar Health Inc Earnings Call Transcript
May 07, 2024 / 12:00PM GMT
Key Points
Positve
- Oscar Health Inc reported a significant year-over-year revenue increase of 46%, reaching $2.1 billion in the first quarter.
- The company achieved positive net income for the first time, reporting $178 million, marking a $217 million improvement from the previous year.
- Membership growth was robust, with a 42% increase year over year, driven by strong retention and growth in both existing and new markets.
- Oscar Health Inc reported an improved medical loss ratio of 74.2%, a 210 basis point improvement compared to the previous year.
- The company successfully launched new products and initiatives, such as the Spanish first program 'HolaOscar', which showed significant growth and high retention among Spanish-speaking members.
Negative
- Despite the positive developments, there are uncertainties regarding the continuation of strong Special Enrollment Period (SEP) growth and its potential impact on medical loss ratio (MLR).
- Oscar Health Inc announced the non-renewal of the Cigna + Oscar small-group offering in 2025, indicating a strategic shift but also posing challenges in transitioning and finding alternative profitable models.
- The company is exiting the Medicare Advantage market due to unsustainable provider relationships, which could impact its product diversity and revenue streams.
- There are ongoing challenges with risk adjustment factors, which could affect future revenue and profitability as the year progresses.
- Administrative costs, while improved, still represent a significant portion of expenses, and further efficiency gains are necessary to sustain profitability.
Operator
Good morning. My name is Allie, and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health's first quarter 2024 earnings conference call. Please note that this call is being recorded. (Operator Instructions) I will now turn the conference over to Chris Potochar, Vice President of Treasury and Investor Relations. Please go ahead.
Chris Potochar
Oscar Health Inc - VP, IR
Good morning, everyone. Thank you for joining us for our first quarter 2024 earnings call. Mark Bertolini, Oscar's Chief Executive Officer, and
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot